MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20552173261475519

Медицинская библиотека · Multiple sclerosis journal - experimental, translational and clinical · 2026

Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT).

Meyer Björn, Nelles Gereon, Betz Linda, Bergmann Arnfin, Jauch-Chara Kamila, Krause Nicole, Riemann Karin, von Glasenapp Barbara, Heesen Christoph

СтатьяПеревод в очереди

Аннотация

BACKGROUND

People with multiple sclerosis (pwMS) often experience impaired quality of life (QoL) despite receiving standard care. Digital therapeutics (DTx) may offer support, but prior trials yielded mixed results, possibly due to active controls and high baseline QoL.

OBJECTIVES

We evaluated a DTx (levidex) as an adjunct to treatment as usual (TAU) in pwMS with impaired QoL.

METHODS

In this pragmatic, online randomized controlled trial (LAMONT; NCT06090305), n = 470 pwMS with a score ≥ 2 on the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS) were randomized to levidex + TAU or TAU alone. The primary endpoint was HAQUAMS total score at 6 months, analysed by intention-to-treat analysis of covariance.

RESULTS

Compared with TAU, levidex + TAU improved multiple sclerosis-specific QoL at 6 months (baseline-adjusted mean difference -0.10; 95% CI -0.18 to -0.03; p = 0.008; Cohen's d = 0.26). Clinically relevant HAQUAMS improvement (≥0.22) occurred more often with levidex (39.5% vs. 27.8%; number needed to treat = 9). Benefits also emerged for depressive symptoms and social/work functioning but not for anxiety. No serious adverse events occurred, and user satisfaction was high.

CONCLUSIONS

In pwMS with impaired QoL, adding the scalable DTx levidex to TAU yields meaningful improvements in QoL and functioning.

Для цитирования: Meyer Björn, Nelles Gereon, Betz Linda, Bergmann Arnfin, Jauch-Chara Kamila, Krause Nicole, Riemann Karin, von Glasenapp Barbara, Heesen Christoph. Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT).. Multiple sclerosis journal - experimental, translational and clinical. 2026. DOI: 10.1177/20552173261475519.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.